Medication info

Tobrasin Eye Drops (Tobramycin)

Prescription medicationEye drops
Ingredient · strength
Tobramycin›3mg / 1mL
Manufacturer / importer
Samchundang Pharmaceutical Co., Ltd.
Appearance
Colorless to pale yellow eye drops in a clear plastic container.
Packaging
5mL/bottle
Approval status
Active

MFDS item code 199400800 · Notified 1994.08.26 · Insurance code 651201851

Summary

Main use
Treatment of eye infections (conjunctivitis, keratitis, etc.) and other bacterial infections (pneumonia, etc.)
Who uses it
Adults · Children
Adult dosage
(Injection) 1. Adults: For severe infections, administer tobramycin 3mg (potency) per kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency) per kg of body weight per day may be administered in 3~4 divided doses. When symptoms improve, the dose should be reduced to 3mg (potency) per kg of body weight per day. Do not administer more than 5mg (potency) per kg of body weight per day without measuring serum concentrations. Treatment usually lasts 7~10 days. The duration may be extended according to the severity of the infection; in such cases, monitor renal, vestibular, and auditory function (neurotoxicity occurs more frequently when treatment lasts longer than 10 days.). 3. Patients with renal failure Measure the serum concentration of this drug whenever possible. Administer an initial dose of 1mg (potency) per kg of body weight, then reduce the dose or extend the dosing interval from the second dose onward. If the serum concentration of this drug cannot be measured directly, calculate the dose based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, these methods should not be used during dialysis. 1) Dose reduction (dosing interval 8 hours): If creatinine clearance is 70mL/min or less, or if the serum creatinine concentration is known, calculate the dose by multiplying the dose for a patient with normal renal function by the applicable % value in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for a patient with normal renal function by the serum creatinine concentration. 2) Extension of the dosing interval (same dose as for patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer at intervals calculated by multiplying the serum creatinine concentration by 6. Adjust the dose as appropriate according to age and symptoms. <Preparation of this drug> For intramuscular injection, dissolve in 1.5mL of normal saline injection or Water for Injection. For intravenous injection in adults, dilute the dose in 50~100mL of normal saline injection or 5% dextrose injection and administer by intravenous drip over 20~60 minutes. (Eye drops) For mild to moderate infections, instill 1~2 drops into the affected area every 4 hours. For severe infections, instill 2 drops every hour until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms. (Ophthalmic ointment) For mild to moderate infections, squeeze approximately 1cm into the affected area 2~3 times a day. For severe infections, apply 1cm to the affected area every 3~4 hours until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms.
Children's dosage
Children: Administer 5mg (potency) per kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Newborns (less than 1 week old): Administer 4mg (potency) per kg of body weight per day in divided doses every 12 hours. For children, reduce the volume of diluent proportionally.

Ingredients

Manufacturer
Samchundang Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of eye infections (conjunctivitis, keratitis, etc.) and other bacterial infections (pneumonia, etc.)

  • Meningitis
  • central nervous system infections
  • bronchitis
  • bronchiectasis
  • pneumonia
  • peritonitis
  • gastrointestinal infections
  • subcutaneous abscesses
  • furuncles
  • soft tissue infections
  • burns
  • wound infections
View approved original text

This injection is used to treat infections caused by various bacteria such as Pseudomonas, Proteus, and Escherichia coli. It is primarily effective against meningitis, pneumonia, peritonitis, osteomyelitis, and various skin and soft tissue infections. It is also applicable for severe urinary tract infections such as sepsis, pyelonephritis, and cystitis. Forms of eye drops or ointments are used to treat infections around the eyes such as blepharitis, dacryocystitis, styes, conjunctivitis, and keratitis. This medication effectively improves symptoms of infections caused by various bacteria and helps in the rapid recovery of patients.

Dosage and Administration

Adult dosage

(Injection) 1. Adults: For severe infections, administer tobramycin 3mg (potency) per kg of body weight per day in 3 divided doses by intravenous or intramuscular injection. For life-threatening infections, up to 5mg (potency) per kg of body weight per day may be administered in 3~4 divided doses. When symptoms improve, the dose should be reduced to 3mg (potency) per kg of body weight per day. Do not administer more than 5mg (potency) per kg of body weight per day without measuring serum concentrations. Treatment usually lasts 7~10 days. The duration may be extended according to the severity of the infection; in such cases, monitor renal, vestibular, and auditory function (neurotoxicity occurs more frequently when treatment lasts longer than 10 days.). 3. Patients with renal failure Measure the serum concentration of this drug whenever possible. Administer an initial dose of 1mg (potency) per kg of body weight, then reduce the dose or extend the dosing interval from the second dose onward. If the serum concentration of this drug cannot be measured directly, calculate the dose based on creatinine clearance or serum creatinine concentration, and adjust the dose while monitoring the patient's condition. However, these methods should not be used during dialysis. 1) Dose reduction (dosing interval 8 hours): If creatinine clearance is 70mL/min or less, or if the serum creatinine concentration is known, calculate the dose by multiplying the dose for a patient with normal renal function by the applicable % value in <Table 1>. If the patient's steady-state serum creatinine concentration is known, an approximate dose can be calculated by dividing the dose for a patient with normal renal function by the serum creatinine concentration. 2) Extension of the dosing interval (same dose as for patients with normal renal function): If the patient's creatinine clearance cannot be measured and the patient's condition is stable, administer at intervals calculated by multiplying the serum creatinine concentration by 6. Adjust the dose as appropriate according to age and symptoms. <Preparation of this drug> For intramuscular injection, dissolve in 1.5mL of normal saline injection or Water for Injection. For intravenous injection in adults, dilute the dose in 50~100mL of normal saline injection or 5% dextrose injection and administer by intravenous drip over 20~60 minutes. (Eye drops) For mild to moderate infections, instill 1~2 drops into the affected area every 4 hours. For severe infections, instill 2 drops every hour until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms. (Ophthalmic ointment) For mild to moderate infections, squeeze approximately 1cm into the affected area 2~3 times a day. For severe infections, apply 1cm to the affected area every 3~4 hours until symptoms improve, then gradually reduce and discontinue. Adjust the dose as appropriate according to age and symptoms.

Children's dosage

Children: Administer 5mg (potency) per kg of body weight per day in 3~4 divided doses by intravenous or intramuscular injection. Newborns (less than 1 week old): Administer 4mg (potency) per kg of body weight per day in divided doses every 12 hours. For children, reduce the volume of diluent proportionally.

Precautions

This medication is an aminoglycoside antibiotic primarily used for treating infections. This medication should not be used for certain patients. For instance, it is unsafe for patients who are allergic to this medication, aminoglycoside antibiotics, or bacitracin, individuals with inner or middle ear diseases, severe renal failure, pregnant or nursing women, patients with muscular disorders, those with bronchial asthma, and patients with disorders of the eighth cranial nerve. Moreover, this medication should be used cautiously for patients with a family history of hearing loss, those with poor renal function, patients with liver impairment, premature infants and newborns, the elderly, and individuals with poor nutritional status. While using this medication, it is important to monitor for various side effects that may occur infrequently, such as shock, nausea, vomiting, loss of appetite, blood abnormalities, dizziness, tinnitus, hearing loss, ear pain, a feeling of ear blockage, numbness of lips or limbs, drowsiness, headache, somnolence, mental confusion, loss of local sensation, heavy feeling, nonsensical speech, directional sense loss, ALT elevation, AST elevation, increased serum LDH, elevated bilirubin, increased BUN, and elevated NPN. Particularly, because this medication can affect the kidneys or hearing, it is recommended that the treatment duration not exceed 10 days if possible, and if necessary, regular blood concentration and hearing tests are important. This medication may interact with other drugs, so caution is required when using it in combination with blood substitutes or specific anesthetics, muscle relaxants, anticoagulants, loop diuretics, etc., that may affect kidney function. During pregnancy, it may cause neurological abnormalities in newborns, so it should only be administered when absolutely necessary. In breastfeeding, it may be transmitted into breast milk, so discontinuation of breastfeeding is recommended during its use. For children and the elderly, kidney function may be weaker, so dosages and administration intervals should be adjusted and used with caution. In case of overdose, serious side effects such as renal and auditory impairment, respiratory suppression, etc., may occur, necessitating immediate appropriate medical treatment. When using eye drops or ointment, localized itching, redness, and irritation around the eyes may occur, and it is advisable to avoid wearing contact lenses. In addition, to prevent the emergence of resistant bacteria, it should be used for the minimum necessary duration as determined by sensitivity testing, and care should be taken as prolonged and repeated use may lead to excessive growth of resistant bacteria. This medication should not be injected directly into the eye, and care should be taken to avoid contact between the end of the tube and the eye surface during administration.

Side effects

shock

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air or moisture, so it should be stored in a tightly sealed container. It is also advisable to store it at normal room temperature, avoiding extreme heat or cold.

Appearance and packaging

Appearance

Colorless to pale yellow eye drops in a clear plastic container.

Package unit

5mL/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.